AG˹ٷ

STOCK TITAN

[424B2] Morgan Stanley Prospectus Supplement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

Instrument: Morgan Stanley Finance LLC Contingent Income Memory Auto-Callable Securities due July 7, 2026, fully and unconditionally guaranteed by Morgan Stanley.

Structure & Pay-offs

  • Principal at risk: repayment of the $1,000 principal is protected only if the final price of Hims & Hers Health, Inc. ("HIMS") Class A shares is � $36.642 (60 % of the $61.07 initial level). Below that threshold, investors lose 1 % of principal for each 1 % decline in the stock, potentially down to $0.
  • Contingent coupon: a rich 47.30 % p.a. (� $118.25 per quarter) is paid only when the closing share price on an observation date is � the 60 % coupon barrier ($36.642). Missed coupons “accrue� and are payable on the next date the barrier is met, but no interest compounds.
  • Automatic early redemption: if on the first and only call test date (Apr 1 2026) HIMS closes � $61.07 (100 % of the initial level) the note is redeemed at par plus the then-due coupon and any accrued coupons; no further payments thereafter.
  • Maturity payment: If not called and the final level is � 60 % of initial, holders receive par plus any due coupon(s); otherwise they receive par × (final/initial).

Key Terms

  • Issue price: $1,000 (minimum ticket $10,000); aggregate size: $500,000.
  • Estimated value at pricing: $964.00 (reflects issuer’s models, funding spread and embedded fees).
  • Fees: up to $10 per note to placement agents (J.P. Morgan entities); proceeds to issuer $990.
  • Observation / coupon dates: Oct 1 2025, Jan 2 2026, Apr 1 2026, Jul 1 2026 (final).
  • Listing: none; MS & Co. may provide, but is not obliged to make, a secondary market.
  • Credit risk: unsecured obligation of MSFL, guaranteed by Morgan Stanley senior debt.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Investor Profile & Risks

The note targets yield-oriented investors willing to accept (i) single-name equity risk in a relatively young, high-volatility stock, (ii) potential loss of principal below a 40 % drawdown, (iii) the possibility of receiving few or no coupons, and (iv) limited liquidity. The elevated coupon compensates for these risks and for the fact the bond can be called at par after nine months, capping upside.

Notable Considerations

  • The first (and only) call test occurs just three months before maturity, reducing reinvestment risk versus structures with monthly call tests.
  • The estimated value is 3.6 % below issue price, signalling an initial mark-to-market drag.
  • Tax treatment is uncertain; issuer counsel views the note as a prepaid forward with ordinary-income coupons, but IRS could disagree.

Strumento: Morgan Stanley Finance LLC Titoli Auto-Richiamabili a Reddito Contingente con Memoria, scadenza 7 luglio 2026, garantiti in modo pieno e incondizionato da Morgan Stanley.

Struttura e Rendimenti

  • Capitale a rischio: il rimborso del capitale di $1.000 è protetto solo se il prezzo finale delle azioni Classe A di Hims & Hers Health, Inc. ("HIMS") è � $36,642 (60% del livello iniziale di $61,07). Sotto questa soglia, gli investitori perdono l'1% del capitale per ogni 1% di calo del titolo, potenzialmente fino a $0.
  • Coupon contingente: un ricco 47,30% annuo (circa $118,25 trimestrali) viene pagato solo se il prezzo di chiusura alla data di osservazione è � alla barriera coupon del 60% ($36,642). I coupon non pagati "accumulano" e sono versabili alla successiva data in cui la barriera è raggiunta, ma non si capitalizzano interessi.
  • Rimborso anticipato automatico: se alla prima e unica data di call (1 aprile 2026) HIMS chiude � $61,07 (100% del livello iniziale), il titolo viene rimborsato a valore nominale più il coupon dovuto e eventuali coupon accumulati; nessun pagamento ulteriore.
  • Pagamento a scadenza: se non richiamato e il livello finale è � 60% dell’iniziale, i detentori ricevono il valore nominale più eventuali coupon dovuti; altrimenti ricevono valore nominale × (finale/iniziale).

Termini Chiave

  • Prezzo di emissione: $1.000 (taglio minimo $10.000); dimensione totale: $500.000.
  • Valore stimato al pricing: $964,00 (riflette modelli dell’emittente, spread di finanziamento e commissioni incorporate).
  • Commissioni: fino a $10 per titolo agli agenti di collocamento (entità J.P. Morgan); proventi netti per emittente $990.
  • Date di osservazione/coupon: 1 ottobre 2025, 2 gennaio 2026, 1 aprile 2026, 1 luglio 2026 (finale).
  • Quotazione: nessuna; MS & Co. può fornire, ma non è obbligata a garantire, un mercato secondario.
  • Rischio di credito: obbligazione non garantita di MSFL, garantita dal debito senior di Morgan Stanley.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Profilo dell’Investitore e Rischi

Il titolo è rivolto a investitori orientati al rendimento disposti ad accettare (i) rischio azionario su una singola società giovane e ad alta volatilità, (ii) possibile perdita di capitale oltre un calo del 40%, (iii) la possibilità di ricevere pochi o nessun coupon, e (iv) liquidità limitata. Il coupon elevato compensa questi rischi e il fatto che il bond possa essere richiamato a valore nominale dopo nove mesi, limitando il potenziale guadagno.

Considerazioni Rilevanti

  • Il primo (e unico) test di call avviene solo tre mesi prima della scadenza, riducendo il rischio di reinvestimento rispetto a strutture con test mensili.
  • Il valore stimato è il 3,6% inferiore al prezzo di emissione, indicando un impatto negativo iniziale sul mark-to-market.
  • Il trattamento fiscale è incerto; il consulente dell’emittente considera il titolo come un forward prepagato con coupon tassati come reddito ordinario, ma l’IRS potrebbe avere un’opinione diversa.

Instrumento: Morgan Stanley Finance LLC Valores Auto-Callable con Ingreso Contingente y Memoria, vencimiento 7 de julio de 2026, garantizados total e incondicionalmente por Morgan Stanley.

Estructura y Pagos

  • Principal en riesgo: el reembolso del principal de $1,000 está protegido solo si el precio final de las acciones Clase A de Hims & Hers Health, Inc. ("HIMS") es � $36.642 (60% del nivel inicial de $61.07). Por debajo de ese umbral, los inversores pierden 1% del principal por cada 1% de caída en la acción, potencialmente hasta $0.
  • Cupones contingentes: un alto 47,30 % anual (aprox. $118.25 trimestrales) se paga solo cuando el precio de cierre en la fecha de observación es � la barrera del cupón del 60% ($36.642). Los cupones no pagados "acumulan" y se pagan en la siguiente fecha en que se cumple la barrera, pero no se capitalizan intereses.
  • Redención anticipada automática: si en la primera y única fecha de llamada (1 de abril de 2026) HIMS cierra � $61.07 (100% del nivel inicial), el bono se redime a la par más el cupón debido y cualquier cupón acumulado; no hay pagos posteriores.
  • Pago al vencimiento: si no es llamado y el nivel final es � 60% del inicial, los tenedores reciben el principal más cualquier cupón debido; de lo contrario, reciben principal × (final/inicial).

Términos Clave

  • Precio de emisión: $1,000 (ticket mínimo $10,000); tamaño agregado: $500,000.
  • Valor estimado en la fijación de precio: $964.00 (refleja modelos del emisor, spread de financiación y comisiones incorporadas).
  • Comisiones: hasta $10 por nota para agentes colocadores (entidades J.P. Morgan); ingresos netos para el emisor $990.
  • Fechas de observación/cupón: 1 de octubre de 2025, 2 de enero de 2026, 1 de abril de 2026, 1 de julio de 2026 (final).
  • Listado: ninguno; MS & Co. puede proporcionar, pero no está obligado a ofrecer, un mercado secundario.
  • Riesgo crediticio: obligación no garantizada de MSFL, garantizada por deuda senior de Morgan Stanley.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Perfil del Inversor y Riesgos

La nota está dirigida a inversores orientados al rendimiento dispuestos a aceptar (i) riesgo de acciones de una sola empresa joven y de alta volatilidad, (ii) posible pérdida de principal ante una caída del 40%, (iii) la posibilidad de recibir pocos o ningún cupón, y (iv) liquidez limitada. El cupón elevado compensa estos riesgos y el hecho de que el bono pueda ser llamado a la par después de nueve meses, limitando el potencial de ganancia.

Consideraciones Notables

  • La primera (y única) prueba de llamada ocurre solo tres meses antes del vencimiento, reduciendo el riesgo de reinversión comparado con estructuras con pruebas mensuales.
  • El valor estimado es un 3.6% inferior al precio de emisión, indicando un impacto inicial negativo en el mark-to-market.
  • El tratamiento fiscal es incierto; el asesor legal del emisor considera la nota como un forward prepago con cupones sujetos a ingreso ordinario, pero el IRS podría tener una opinión diferente.

: Morgan Stanley Finance LLC� 조건부 소득 메모� 자동 상환 증권, 만기 2026� 7� 7�, Morgan Stanley가 전액 무조건적으로 보증�.

구조 � 수익

  • 원금 위험: Hims & Hers Health, Inc.("HIMS") 클래� A 주식� 최종 가격이 $36.642(초기 수준 $61.07� 60%) 이상� 경우에만 $1,000 원금 상환� 보호됩니�. � 임계� 이하에서� 주가가 1% 하락� 때마� 원금� 1%� 잃게 되며, 최악� 경우 $0까지 손실� 발생� � 있습니다.
  • 조건부 쿠폰: � 47.30%� 높은 수익�(분기� � $118.25)� 관찰일� 종가가 60% 쿠폰 장벽($36.642) 이상� 때만 지급됩니다. 놓친 쿠폰은 "누적"되어 다음� 장벽� 충족하는 날짜� 지급되지� 이자� 복리� 계산되지 않습니다.
  • 자동 조기 상환: � 번째이자 유일� � 테스트일(2026� 4� 1�)� HIMS가 $61.07(초기 수준� 100%) 이상으로 마감하면, 채권은 액면가와 해당 시점� 쿠폰 � 누적 쿠폰� 함께 상환되며 이후 추가 지급은 없습니다.
  • 만기 지�: 콜되지 않고 최종 가격이 초기 가격의 60% 이상� 경우, 보유자는 액면가와 해당 쿠폰� 받으�, 그렇지 않으� 액면가 × (최종/초기)� 받습니다.

주요 조건

  • 발행 가�: $1,000 (최소 투자금액 $10,000); � 발행 규모: $500,000.
  • 가� 책정 � 추정 가�: $964.00 (발행자의 모델, 자금 조달 스프레드 � 내재 수수� 반영).
  • 수수�: 노트� 최대 $10� 배치 대리인(J.P. Morgan 계열�)� 지�; 발행� 수익은 $990.
  • 관�/쿠폰 지급일: 2025� 10� 1�, 2026� 1� 2�, 2026� 4� 1�, 2026� 7� 1�(최종).
  • 상장: 없음; MS & Co.� 2� 시장� 제공� � 있으� 의무� 아님.
  • 신용 위험: MSFL� 무담� 채무이며 Morgan Stanley 선순� 부채가 보증�.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

투자� 프로� � 위험

� 노트� (i) 비교� 젊고 변동성� 높은 단일 주식 위험� 감수� � 있는 수익 지� 투자�, (ii) 40% 하락 � 원금 손실 가능성, (iii) 쿠폰 지급이 적거� 없을 가능성, (iv) 제한� 유동성을 감수� 투자자를 대상으� 합니�. 높은 쿠폰은 이러� 위험� 9개월 � 액면가� 콜될 � 있어 상승 잠재력이 제한되는 점을 보상합니�.

주요 고려사항

  • � 번째이자 유일� � 테스트가 만기 3개월 전에 이루어져 월별 � 테스� 구조 대� 재투� 위험� 줄어듭니�.
  • 추정 가치는 발행가보다 3.6% 낮아 초기 시장 가� 하락� 시사합니�.
  • 세금 처리� 불확실성� 있으�, 발행� 자문은 � 노트� 선불 선도계약으로 보고 쿠폰� 일반 소득으로 간주하지� IRS� 다르� 판단� � 있습니다.

Instrument : Morgan Stanley Finance LLC Titres Auto-Rappelables à Revenu Conditionnel avec Mémoire, échéance le 7 juillet 2026, garantis de manière pleine et inconditionnelle par Morgan Stanley.

Structure et Rendements

  • Capital à risque : le remboursement du principal de 1 000 $ est protégé uniquement si le prix final des actions de classe A de Hims & Hers Health, Inc. ("HIMS") est � 36,642 $ (60 % du niveau initial de 61,07 $). En dessous de ce seuil, les investisseurs perdent 1 % du principal pour chaque baisse de 1 % du titre, pouvant aller jusqu’� 0 $.
  • Coupon conditionnel : un généreux 47,30 % par an (environ 118,25 $ par trimestre) est payé uniquement lorsque le cours de clôture à une date d’observation est � à la barrière de coupon à 60 % (36,642 $). Les coupons manqués « s’accumulent » et sont payables à la prochaine date où la barrière est atteinte, mais sans capitalisation des intérêts.
  • Remboursement anticipé automatique : si à la première et unique date de test de rappel (1er avril 2026) HIMS clôture � 61,07 $ (100 % du niveau initial), la note est remboursée à la valeur nominale plus le coupon dû et tous les coupons accumulés ; aucun paiement ultérieur.
  • Versement à l’échéance : si la note n’est pas rappelée et que le niveau final est � 60 % de l’initial, les détenteurs reçoivent la valeur nominale plus les coupons dus ; sinon, ils reçoivent la valeur nominale × (final/initial).

Conditions Clés

  • Prix d’émission : 1 000 $ (ticket minimum 10 000 $) ; taille totale : 500 000 $.
  • Valeur estimée à la fixation du prix : 964,00 $ (intègre les modèles de l’émetteur, le spread de financement et les frais incorporés).
  • Frais : jusqu’� 10 $ par note pour les agents de placement (entités J.P. Morgan) ; produit net pour l’émetteur 990 $.
  • Dates d’observation/coupon : 1er oct. 2025, 2 janv. 2026, 1er avr. 2026, 1er juil. 2026 (finale).
  • Listing : aucun ; MS & Co. peut fournir, mais n’est pas obligé d’assurer, un marché secondaire.
  • Risque de crédit : obligation non garantie de MSFL, garantie par la dette senior de Morgan Stanley.
  • CUSIP/ISIN : 61778K6M4 / US61778K6M47.

Profil Investisseur & Risques

La note cible les investisseurs orientés rendement prêts à accepter (i) un risque actions sur une société relativement jeune et très volatile, (ii) une perte potentielle de capital en cas de baisse de plus de 40 %, (iii) la possibilité de recevoir peu ou pas de coupons, et (iv) une liquidité limitée. Le coupon élevé compense ces risques ainsi que le fait que l’obligation puisse être rappelée à la valeur nominale après neuf mois, limitant ainsi le potentiel de gain.

Considérations Notables

  • Le premier (et unique) test de rappel intervient seulement trois mois avant l’échéance, réduisant le risque de réinvestissement par rapport aux structures avec tests mensuels.
  • La valeur estimée est inférieure de 3,6 % au prix d’émission, indiquant un impact initial négatif en mark-to-market.
  • Le traitement fiscal est incertain ; le conseil de l’émetteur considère la note comme un contrat à terme prépayé avec coupons imposés comme revenu ordinaire, mais l’IRS pourrait avoir un avis différent.

Instrument: Morgan Stanley Finance LLC Bedingte Einkommens-Memory-Auto-Callable-Wertpapiere mit Fälligkeit am 7. Juli 2026, vollumfänglich und bedingungslos von Morgan Stanley garantiert.

Struktur & Auszahlungen

  • Kapitalrisiko: Die Rückzahlung des $1.000 Kapitals ist nur geschützt, wenn der Schlusskurs der Hims & Hers Health, Inc. ("HIMS") Class A Aktien � $36,642 beträgt (60 % des Anfangsniveaus von $61,07). Liegt der Kurs darunter, verlieren Anleger 1 % des Kapitals für jeden 1 % Kursrückgang, mit möglichem Totalverlust bis auf $0.
  • Bedingter Kupon: Ein attraktiver Jahreszins von 47,30 % (ca. $118,25 pro Quartal) wird nur gezahlt, wenn der Schlusskurs am Beobachtungstag � der 60 % Kupon-Schwelle ($36,642) liegt. Verpasste Kupons „akkumulieren� und werden bei der nächsten Erreichung der Schwelle ausgezahlt, jedoch ohne Zinseszinsen.
  • Automatische vorzeitige Rückzahlung: Wenn am ersten und einzigen Call-Testdatum (1. April 2026) HIMS � $61,07 (100 % des Anfangsniveaus) schließt, wird die Note zum Nennwert plus dem fälligen Kupon und etwaigen akkumulierten Kupons zurückgezahlt; danach keine weiteren Zahlungen.
  • Zahlung bei Fälligkeit: Wird die Note nicht zurückgerufen und liegt das Endniveau � 60 % des Anfangswerts, erhalten die Inhaber den Nennwert plus fällige Kupons; andernfalls erhalten sie Nennwert × (Endniveau/Anfangsniveau).

Wesentliche Bedingungen

  • Ausgabepreis: $1.000 (Mindestanlage $10.000); Gesamtvolumen: $500.000.
  • Geschätzter Wert bei Pricing: $964,00 (berücksichtigt Emittentenmodelle, Finanzierungsspread und eingebettete Gebühren).
  • Gebühren: bis zu $10 pro Note für Platzierungsagenten (J.P. Morgan Einheiten); Erlös für Emittent $990.
  • Beobachtungs-/Kupondaten: 1. Okt 2025, 2. Jan 2026, 1. Apr 2026, 1. Jul 2026 (Endtermin).
  • Listing: keines; MS & Co. kann, ist aber nicht verpflichtet, einen Sekundärmarkt stellen.
  • Kreditrisiko: unbesicherte Verbindlichkeit von MSFL, garantiert durch Morgan Stanley Senior Debt.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Investorprofil & Risiken

Die Note richtet sich an renditeorientierte Anleger, die bereit sind, (i) Einzelaktienrisiko in einer relativ jungen, hochvolatilen Aktie zu akzeptieren, (ii) potenziellen Kapitalverlust bei einem Rückgang von mehr als 40 %, (iii) die Möglichkeit, wenige oder keine Kupons zu erhalten, und (iv) eingeschränkte Liquidität hinzunehmen. Der hohe Kupon kompensiert diese Risiken sowie die Tatsache, dass die Anleihe nach neun Monaten zum Nennwert zurückgerufen werden kann, was die Gewinnchancen begrenzt.

Wichtige Hinweise

  • Der erste (und einzige) Call-Test findet nur drei Monate vor Fälligkeit statt, was das Reinvestitionsrisiko im Vergleich zu Strukturen mit monatlichen Call-Tests verringert.
  • Der geschätzte Wert liegt 3,6 % unter dem Ausgabepreis, was auf einen anfänglichen Mark-to-Market-Nachteil hinweist.
  • Die steuerliche Behandlung ist unsicher; der Emittentenberater betrachtet die Note als vorab bezahlten Forward mit Kupons als ordentliche Einkünfte, aber das IRS könnte anderer Meinung sein.
Positive
  • Very high contingent coupon of 47.30 % per annum, far above current high-yield bond rates, offering substantial income if barrier conditions are met.
  • Single, late call date (Apr 1 2026) limits early redemption frequency, allowing more coupon accrual before potential call.
  • Full Morgan Stanley guarantee provides investment-grade credit backing despite the principal-at-risk equity component.
Negative
  • Principal fully at risk below 60 % barrier; a 40 % decline in HIMS triggers 1-for-1 capital loss, potentially wiping out the investment.
  • No upside participation; equity gains above initial level benefit issuer through automatic call at par, capping investor return.
  • Estimated value is 3.6 % below issue price, reflecting embedded fees and internal funding rate; investors start at a mark-to-market deficit.
  • Unlisted and thin secondary market could lead to significant liquidity discounts for early sellers.
  • Tax treatment uncertain; coupons likely ordinary income and potential withholding for non-U.S. holders.

Insights

TL;DR: 47.3 % coupon attractive, but payoff highly binary on volatile HIMS stock; early call likely if shares rebound; principal fully at risk below �40 %.

Analysis: HIMS has shown large price swings since its 2021 listing, making the 60 % barrier a meaningful, yet not remote, trigger. Investors earn nothing beyond coupons; any upside above par accrues to issuer via the embedded call. The single call date minimizes continual call risk, yet if HIMS trades flat to modestly higher, redemption in April 2026 is probable, shortening the 13-month intended tenor to about 9 months. The effective yield, if all coupons are paid and no call occurs, approximates 47 % simple (� 53 % annualised on a 1-year term), far above high-yield corporates, reflecting equity and credit risk. Liquidity is thin; the note is small ($0.5 mm) and unlisted, so exit valuations will embed wide spreads. Overall, the structure is suited to speculative income seekers who can monitor HIMS price action and tolerate capital loss.

TL;DR: Note embeds 1× short put on HIMS at 60 % strike plus short call at 100 % strike; investors assume equity tail risk and Morgan Stanley credit.

The security synthetically combines: (i) long MSFL zero-coupon bond, (ii) short down-and-in put struck at 60 %, (iii) short digital call that redeems notes at par when HIMS � 100 % on Apr 1 2026. Implied volatility and dividend assumptions favour the issuer; investors pay 3.6 % premium over model value. Barrier at 60 % appears close given HIMS β�1.8 and 30-day realised vol near 55 %. Historical drawdowns exceeded 60 % twice since IPO. If barrier breaches early, mark-to-market losses could reach 30-40 % quickly. Credit spread widening of Morgan Stanley would exacerbate losses. Risk/return therefore skews negative unless investors have constructive view on HIMS stability.

Strumento: Morgan Stanley Finance LLC Titoli Auto-Richiamabili a Reddito Contingente con Memoria, scadenza 7 luglio 2026, garantiti in modo pieno e incondizionato da Morgan Stanley.

Struttura e Rendimenti

  • Capitale a rischio: il rimborso del capitale di $1.000 è protetto solo se il prezzo finale delle azioni Classe A di Hims & Hers Health, Inc. ("HIMS") è � $36,642 (60% del livello iniziale di $61,07). Sotto questa soglia, gli investitori perdono l'1% del capitale per ogni 1% di calo del titolo, potenzialmente fino a $0.
  • Coupon contingente: un ricco 47,30% annuo (circa $118,25 trimestrali) viene pagato solo se il prezzo di chiusura alla data di osservazione è � alla barriera coupon del 60% ($36,642). I coupon non pagati "accumulano" e sono versabili alla successiva data in cui la barriera è raggiunta, ma non si capitalizzano interessi.
  • Rimborso anticipato automatico: se alla prima e unica data di call (1 aprile 2026) HIMS chiude � $61,07 (100% del livello iniziale), il titolo viene rimborsato a valore nominale più il coupon dovuto e eventuali coupon accumulati; nessun pagamento ulteriore.
  • Pagamento a scadenza: se non richiamato e il livello finale è � 60% dell’iniziale, i detentori ricevono il valore nominale più eventuali coupon dovuti; altrimenti ricevono valore nominale × (finale/iniziale).

Termini Chiave

  • Prezzo di emissione: $1.000 (taglio minimo $10.000); dimensione totale: $500.000.
  • Valore stimato al pricing: $964,00 (riflette modelli dell’emittente, spread di finanziamento e commissioni incorporate).
  • Commissioni: fino a $10 per titolo agli agenti di collocamento (entità J.P. Morgan); proventi netti per emittente $990.
  • Date di osservazione/coupon: 1 ottobre 2025, 2 gennaio 2026, 1 aprile 2026, 1 luglio 2026 (finale).
  • Quotazione: nessuna; MS & Co. può fornire, ma non è obbligata a garantire, un mercato secondario.
  • Rischio di credito: obbligazione non garantita di MSFL, garantita dal debito senior di Morgan Stanley.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Profilo dell’Investitore e Rischi

Il titolo è rivolto a investitori orientati al rendimento disposti ad accettare (i) rischio azionario su una singola società giovane e ad alta volatilità, (ii) possibile perdita di capitale oltre un calo del 40%, (iii) la possibilità di ricevere pochi o nessun coupon, e (iv) liquidità limitata. Il coupon elevato compensa questi rischi e il fatto che il bond possa essere richiamato a valore nominale dopo nove mesi, limitando il potenziale guadagno.

Considerazioni Rilevanti

  • Il primo (e unico) test di call avviene solo tre mesi prima della scadenza, riducendo il rischio di reinvestimento rispetto a strutture con test mensili.
  • Il valore stimato è il 3,6% inferiore al prezzo di emissione, indicando un impatto negativo iniziale sul mark-to-market.
  • Il trattamento fiscale è incerto; il consulente dell’emittente considera il titolo come un forward prepagato con coupon tassati come reddito ordinario, ma l’IRS potrebbe avere un’opinione diversa.

Instrumento: Morgan Stanley Finance LLC Valores Auto-Callable con Ingreso Contingente y Memoria, vencimiento 7 de julio de 2026, garantizados total e incondicionalmente por Morgan Stanley.

Estructura y Pagos

  • Principal en riesgo: el reembolso del principal de $1,000 está protegido solo si el precio final de las acciones Clase A de Hims & Hers Health, Inc. ("HIMS") es � $36.642 (60% del nivel inicial de $61.07). Por debajo de ese umbral, los inversores pierden 1% del principal por cada 1% de caída en la acción, potencialmente hasta $0.
  • Cupones contingentes: un alto 47,30 % anual (aprox. $118.25 trimestrales) se paga solo cuando el precio de cierre en la fecha de observación es � la barrera del cupón del 60% ($36.642). Los cupones no pagados "acumulan" y se pagan en la siguiente fecha en que se cumple la barrera, pero no se capitalizan intereses.
  • Redención anticipada automática: si en la primera y única fecha de llamada (1 de abril de 2026) HIMS cierra � $61.07 (100% del nivel inicial), el bono se redime a la par más el cupón debido y cualquier cupón acumulado; no hay pagos posteriores.
  • Pago al vencimiento: si no es llamado y el nivel final es � 60% del inicial, los tenedores reciben el principal más cualquier cupón debido; de lo contrario, reciben principal × (final/inicial).

Términos Clave

  • Precio de emisión: $1,000 (ticket mínimo $10,000); tamaño agregado: $500,000.
  • Valor estimado en la fijación de precio: $964.00 (refleja modelos del emisor, spread de financiación y comisiones incorporadas).
  • Comisiones: hasta $10 por nota para agentes colocadores (entidades J.P. Morgan); ingresos netos para el emisor $990.
  • Fechas de observación/cupón: 1 de octubre de 2025, 2 de enero de 2026, 1 de abril de 2026, 1 de julio de 2026 (final).
  • Listado: ninguno; MS & Co. puede proporcionar, pero no está obligado a ofrecer, un mercado secundario.
  • Riesgo crediticio: obligación no garantizada de MSFL, garantizada por deuda senior de Morgan Stanley.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Perfil del Inversor y Riesgos

La nota está dirigida a inversores orientados al rendimiento dispuestos a aceptar (i) riesgo de acciones de una sola empresa joven y de alta volatilidad, (ii) posible pérdida de principal ante una caída del 40%, (iii) la posibilidad de recibir pocos o ningún cupón, y (iv) liquidez limitada. El cupón elevado compensa estos riesgos y el hecho de que el bono pueda ser llamado a la par después de nueve meses, limitando el potencial de ganancia.

Consideraciones Notables

  • La primera (y única) prueba de llamada ocurre solo tres meses antes del vencimiento, reduciendo el riesgo de reinversión comparado con estructuras con pruebas mensuales.
  • El valor estimado es un 3.6% inferior al precio de emisión, indicando un impacto inicial negativo en el mark-to-market.
  • El tratamiento fiscal es incierto; el asesor legal del emisor considera la nota como un forward prepago con cupones sujetos a ingreso ordinario, pero el IRS podría tener una opinión diferente.

: Morgan Stanley Finance LLC� 조건부 소득 메모� 자동 상환 증권, 만기 2026� 7� 7�, Morgan Stanley가 전액 무조건적으로 보증�.

구조 � 수익

  • 원금 위험: Hims & Hers Health, Inc.("HIMS") 클래� A 주식� 최종 가격이 $36.642(초기 수준 $61.07� 60%) 이상� 경우에만 $1,000 원금 상환� 보호됩니�. � 임계� 이하에서� 주가가 1% 하락� 때마� 원금� 1%� 잃게 되며, 최악� 경우 $0까지 손실� 발생� � 있습니다.
  • 조건부 쿠폰: � 47.30%� 높은 수익�(분기� � $118.25)� 관찰일� 종가가 60% 쿠폰 장벽($36.642) 이상� 때만 지급됩니다. 놓친 쿠폰은 "누적"되어 다음� 장벽� 충족하는 날짜� 지급되지� 이자� 복리� 계산되지 않습니다.
  • 자동 조기 상환: � 번째이자 유일� � 테스트일(2026� 4� 1�)� HIMS가 $61.07(초기 수준� 100%) 이상으로 마감하면, 채권은 액면가와 해당 시점� 쿠폰 � 누적 쿠폰� 함께 상환되며 이후 추가 지급은 없습니다.
  • 만기 지�: 콜되지 않고 최종 가격이 초기 가격의 60% 이상� 경우, 보유자는 액면가와 해당 쿠폰� 받으�, 그렇지 않으� 액면가 × (최종/초기)� 받습니다.

주요 조건

  • 발행 가�: $1,000 (최소 투자금액 $10,000); � 발행 규모: $500,000.
  • 가� 책정 � 추정 가�: $964.00 (발행자의 모델, 자금 조달 스프레드 � 내재 수수� 반영).
  • 수수�: 노트� 최대 $10� 배치 대리인(J.P. Morgan 계열�)� 지�; 발행� 수익은 $990.
  • 관�/쿠폰 지급일: 2025� 10� 1�, 2026� 1� 2�, 2026� 4� 1�, 2026� 7� 1�(최종).
  • 상장: 없음; MS & Co.� 2� 시장� 제공� � 있으� 의무� 아님.
  • 신용 위험: MSFL� 무담� 채무이며 Morgan Stanley 선순� 부채가 보증�.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

투자� 프로� � 위험

� 노트� (i) 비교� 젊고 변동성� 높은 단일 주식 위험� 감수� � 있는 수익 지� 투자�, (ii) 40% 하락 � 원금 손실 가능성, (iii) 쿠폰 지급이 적거� 없을 가능성, (iv) 제한� 유동성을 감수� 투자자를 대상으� 합니�. 높은 쿠폰은 이러� 위험� 9개월 � 액면가� 콜될 � 있어 상승 잠재력이 제한되는 점을 보상합니�.

주요 고려사항

  • � 번째이자 유일� � 테스트가 만기 3개월 전에 이루어져 월별 � 테스� 구조 대� 재투� 위험� 줄어듭니�.
  • 추정 가치는 발행가보다 3.6% 낮아 초기 시장 가� 하락� 시사합니�.
  • 세금 처리� 불확실성� 있으�, 발행� 자문은 � 노트� 선불 선도계약으로 보고 쿠폰� 일반 소득으로 간주하지� IRS� 다르� 판단� � 있습니다.

Instrument : Morgan Stanley Finance LLC Titres Auto-Rappelables à Revenu Conditionnel avec Mémoire, échéance le 7 juillet 2026, garantis de manière pleine et inconditionnelle par Morgan Stanley.

Structure et Rendements

  • Capital à risque : le remboursement du principal de 1 000 $ est protégé uniquement si le prix final des actions de classe A de Hims & Hers Health, Inc. ("HIMS") est � 36,642 $ (60 % du niveau initial de 61,07 $). En dessous de ce seuil, les investisseurs perdent 1 % du principal pour chaque baisse de 1 % du titre, pouvant aller jusqu’� 0 $.
  • Coupon conditionnel : un généreux 47,30 % par an (environ 118,25 $ par trimestre) est payé uniquement lorsque le cours de clôture à une date d’observation est � à la barrière de coupon à 60 % (36,642 $). Les coupons manqués « s’accumulent » et sont payables à la prochaine date où la barrière est atteinte, mais sans capitalisation des intérêts.
  • Remboursement anticipé automatique : si à la première et unique date de test de rappel (1er avril 2026) HIMS clôture � 61,07 $ (100 % du niveau initial), la note est remboursée à la valeur nominale plus le coupon dû et tous les coupons accumulés ; aucun paiement ultérieur.
  • Versement à l’échéance : si la note n’est pas rappelée et que le niveau final est � 60 % de l’initial, les détenteurs reçoivent la valeur nominale plus les coupons dus ; sinon, ils reçoivent la valeur nominale × (final/initial).

Conditions Clés

  • Prix d’émission : 1 000 $ (ticket minimum 10 000 $) ; taille totale : 500 000 $.
  • Valeur estimée à la fixation du prix : 964,00 $ (intègre les modèles de l’émetteur, le spread de financement et les frais incorporés).
  • Frais : jusqu’� 10 $ par note pour les agents de placement (entités J.P. Morgan) ; produit net pour l’émetteur 990 $.
  • Dates d’observation/coupon : 1er oct. 2025, 2 janv. 2026, 1er avr. 2026, 1er juil. 2026 (finale).
  • Listing : aucun ; MS & Co. peut fournir, mais n’est pas obligé d’assurer, un marché secondaire.
  • Risque de crédit : obligation non garantie de MSFL, garantie par la dette senior de Morgan Stanley.
  • CUSIP/ISIN : 61778K6M4 / US61778K6M47.

Profil Investisseur & Risques

La note cible les investisseurs orientés rendement prêts à accepter (i) un risque actions sur une société relativement jeune et très volatile, (ii) une perte potentielle de capital en cas de baisse de plus de 40 %, (iii) la possibilité de recevoir peu ou pas de coupons, et (iv) une liquidité limitée. Le coupon élevé compense ces risques ainsi que le fait que l’obligation puisse être rappelée à la valeur nominale après neuf mois, limitant ainsi le potentiel de gain.

Considérations Notables

  • Le premier (et unique) test de rappel intervient seulement trois mois avant l’échéance, réduisant le risque de réinvestissement par rapport aux structures avec tests mensuels.
  • La valeur estimée est inférieure de 3,6 % au prix d’émission, indiquant un impact initial négatif en mark-to-market.
  • Le traitement fiscal est incertain ; le conseil de l’émetteur considère la note comme un contrat à terme prépayé avec coupons imposés comme revenu ordinaire, mais l’IRS pourrait avoir un avis différent.

Instrument: Morgan Stanley Finance LLC Bedingte Einkommens-Memory-Auto-Callable-Wertpapiere mit Fälligkeit am 7. Juli 2026, vollumfänglich und bedingungslos von Morgan Stanley garantiert.

Struktur & Auszahlungen

  • Kapitalrisiko: Die Rückzahlung des $1.000 Kapitals ist nur geschützt, wenn der Schlusskurs der Hims & Hers Health, Inc. ("HIMS") Class A Aktien � $36,642 beträgt (60 % des Anfangsniveaus von $61,07). Liegt der Kurs darunter, verlieren Anleger 1 % des Kapitals für jeden 1 % Kursrückgang, mit möglichem Totalverlust bis auf $0.
  • Bedingter Kupon: Ein attraktiver Jahreszins von 47,30 % (ca. $118,25 pro Quartal) wird nur gezahlt, wenn der Schlusskurs am Beobachtungstag � der 60 % Kupon-Schwelle ($36,642) liegt. Verpasste Kupons „akkumulieren� und werden bei der nächsten Erreichung der Schwelle ausgezahlt, jedoch ohne Zinseszinsen.
  • Automatische vorzeitige Rückzahlung: Wenn am ersten und einzigen Call-Testdatum (1. April 2026) HIMS � $61,07 (100 % des Anfangsniveaus) schließt, wird die Note zum Nennwert plus dem fälligen Kupon und etwaigen akkumulierten Kupons zurückgezahlt; danach keine weiteren Zahlungen.
  • Zahlung bei Fälligkeit: Wird die Note nicht zurückgerufen und liegt das Endniveau � 60 % des Anfangswerts, erhalten die Inhaber den Nennwert plus fällige Kupons; andernfalls erhalten sie Nennwert × (Endniveau/Anfangsniveau).

Wesentliche Bedingungen

  • Ausgabepreis: $1.000 (Mindestanlage $10.000); Gesamtvolumen: $500.000.
  • Geschätzter Wert bei Pricing: $964,00 (berücksichtigt Emittentenmodelle, Finanzierungsspread und eingebettete Gebühren).
  • Gebühren: bis zu $10 pro Note für Platzierungsagenten (J.P. Morgan Einheiten); Erlös für Emittent $990.
  • Beobachtungs-/Kupondaten: 1. Okt 2025, 2. Jan 2026, 1. Apr 2026, 1. Jul 2026 (Endtermin).
  • Listing: keines; MS & Co. kann, ist aber nicht verpflichtet, einen Sekundärmarkt stellen.
  • Kreditrisiko: unbesicherte Verbindlichkeit von MSFL, garantiert durch Morgan Stanley Senior Debt.
  • CUSIP/ISIN: 61778K6M4 / US61778K6M47.

Investorprofil & Risiken

Die Note richtet sich an renditeorientierte Anleger, die bereit sind, (i) Einzelaktienrisiko in einer relativ jungen, hochvolatilen Aktie zu akzeptieren, (ii) potenziellen Kapitalverlust bei einem Rückgang von mehr als 40 %, (iii) die Möglichkeit, wenige oder keine Kupons zu erhalten, und (iv) eingeschränkte Liquidität hinzunehmen. Der hohe Kupon kompensiert diese Risiken sowie die Tatsache, dass die Anleihe nach neun Monaten zum Nennwert zurückgerufen werden kann, was die Gewinnchancen begrenzt.

Wichtige Hinweise

  • Der erste (und einzige) Call-Test findet nur drei Monate vor Fälligkeit statt, was das Reinvestitionsrisiko im Vergleich zu Strukturen mit monatlichen Call-Tests verringert.
  • Der geschätzte Wert liegt 3,6 % unter dem Ausgabepreis, was auf einen anfänglichen Mark-to-Market-Nachteil hinweist.
  • Die steuerliche Behandlung ist unsicher; der Emittentenberater betrachtet die Note als vorab bezahlten Forward mit Kupons als ordentliche Einkünfte, aber das IRS könnte anderer Meinung sein.

Pricing Supplement No. 9,005

Registration Statement Nos. 333-275587; 333-275587-01

Dated June 20, 2025

Filed pursuant to Rule 424(b)(2)

Morgan Stanley Finance LLC

Structured Investments

Contingent Income Memory Auto-Callable Securities due July 7, 2026

Based on the Performance of the Class A Common Stock of Hims & Hers Health, Inc.

Fully and Unconditionally Guaranteed by Morgan Stanley

Principal at Risk Securities

The securities are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The securities have the terms described in the accompanying product supplement and prospectus, as supplemented or modified by this document. The securities do not guarantee the repayment of principal and do not provide for the regular payment of interest.

Contingent coupon. The securities will pay a contingent coupon (as well as any previously unpaid contingent coupons) but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. However, if the closing level of the underlier is less than the coupon barrier level on any observation date, we will pay no interest with respect to the related interest period.

Automatic early redemption. The securities will be automatically redeemed if the closing level of the underlier is greater than or equal to the call threshold level on the first redemption determination date for the early redemption payment equal to the stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons. No further payments will be made on the securities once they have been automatically redeemed.

Payment at maturity. If the securities have not been automatically redeemed prior to maturity and the final level is greater than or equal to the downside threshold level, investors will receive (in addition to the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons, if payable) the stated principal amount at maturity. If, however, the final level is less than the downside threshold level, investors will lose 1% for every 1% decline in the level of the underlier over the term of the securities. Under these circumstances, the payment at maturity will be significantly less than the stated principal amount and could be zero.

The securities are for investors who seek an opportunity to earn interest at a potentially above-market rate in exchange for the risk of losing a significant portion or all of their principal and the risk of receiving no coupons over the entire term of the securities. You will not participate in any appreciation of the underlier. Investors in the securities must be willing to accept the risk of losing their entire initial investment. The securities are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.

All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These securities are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.

FINAL TERMS

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Stated principal amount:

$1,000 per security

Issue price:

$1,000 per security (see “Commissions and issue price” below)

Aggregate principal amount:

$500,000

Underlier:

Hims & Hers Health, Inc. class A common stock (the “underlying stock”)

Strike date:

June 18, 2025

Pricing date:

June 20, 2025

Original issue date:

June 25, 2025

Final observation date:

July 1, 2026, subject to postponement for non-trading days and certain market disruption events

Maturity date:

July 7, 2026

Terms continued on the following page

Agent:

Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”

Estimated value on the pricing date:

$964.00 per security. See “Estimated Value of the Securities” on page 4.

Commissions and issue price:

Price to public

Agent’s commissions and fees(1)

Proceeds to us(2)

Per security

$1,000

$10

$990

Total

$500,000

$5,000

$495,000

(1)J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. will act as placement agents for the securities. The placement agents will forgo fees for sales to certain fiduciary accounts. The total fees represent the amount that the placement agents receive from sales to accounts other than such fiduciary accounts. The placement agents will receive a fee from the Issuer or one of its affiliates that will not exceed $10 per $1,000 stated principal amount of securities.

(2)See “Use of Proceeds and Hedging” in the accompanying product supplement.

The securities involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 8.

The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this document or the accompanying product supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The securities are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

You should read this document together with the related product supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see “Additional Terms of the Securities” and “Additional Information About the Securities” at the end of this document.

References to “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.

Product Supplement for Principal at Risk Securities dated February 7, 2025 Prospectus dated April 12, 2024

Morgan Stanley

 

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Terms continued from the previous page

Automatic early redemption:

If, on the first redemption determination date, the closing level of the underlier is greater than or equal to the call threshold level, the securities will be automatically redeemed for the early redemption payment on the early redemption date. No further payments will be made on the securities once they have been automatically redeemed.

First redemption determination date:

April 1, 2026, subject to postponement for non-trading days and certain market disruption events.

Call threshold level:

$61.07, which is 100% of the initial level

Early redemption payment:

The stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons

Early redemption date:

April 6, 2026

Contingent coupon:

A contingent coupon at an annual rate of 47.30% will be paid on the securities on each coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date.

If the contingent coupon is not paid on any coupon payment date (because the closing level of the underlier is less than the coupon barrier level on the related observation date), such unpaid contingent coupon will be paid on a later coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. Any such unpaid contingent coupon will be paid on the first subsequent coupon payment date for which the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date; provided, however, in the case of any such payment of a previously unpaid contingent coupon, no additional interest shall accrue or be payable in respect of such unpaid contingent coupon from and after the end of the original interest period for such unpaid contingent coupon.

You will not receive payment for any unpaid contingent coupons if the closing level of the underlier is less than the coupon barrier level on each subsequent observation date.

Coupon payment dates:

As set forth under “Observation Dates and Coupon Payment Dates” below. If any coupon payment date is not a business day, the coupon payment with respect to such date, if any, will be made on the next succeeding business day and no adjustment will be made to any coupon payment made on that succeeding business day. The coupon payment, if any, with respect to the final observation date shall be made on the maturity date.

Coupon barrier level:

$36.642, which is 60% of the initial level

Observation dates:

As set forth under “Observation Dates and Coupon Payment Dates” below, subject to postponement for non-trading days and certain market disruption events.

Payment at maturity per security:

If the securities have not been automatically redeemed prior to maturity, investors will receive (in addition to the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons, if payable) a payment at maturity determined as follows:

If the final level is greater than or equal to the downside threshold level:

stated principal amount

If the final level is less than the downside threshold level:

stated principal amount × performance factor

Under these circumstances, the payment at maturity will be significantly less than the stated principal amount and could be zero.

Final level:

The closing level of the underlier on the final observation date

Downside threshold level:

$36.642, which is 60% of the initial level

Performance factor:

final level / initial level

Initial level:

$61.07, which is the closing level of the underlier on the strike date

Closing level:

“Closing level” and “adjustment factor” have the meanings set forth under “General Terms of the Securities—Some Definitions” in the accompanying product supplement.

CUSIP:

61778K6M4

ISIN:

US61778K6M47

Listing:

The securities will not be listed on any securities exchange.

 

 Page 2

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Observation Dates and Coupon Payment Dates

Observation Dates

Coupon Payment Dates

October 1, 2025

October 6, 2025

January 2, 2026

January 7, 2026

April 1, 2026

April 6, 2026

July 1, 2026 (final observation date)

July 7, 2026 (maturity date)

 Page 3

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Estimated Value of the Securities

The original issue price of each security is $1,000. This price includes costs associated with issuing, selling, structuring and hedging the securities, which are borne by you, and, consequently, the estimated value of the securities on the pricing date is less than $1,000. Our estimate of the value of the securities as determined on the pricing date is set forth on the cover of this document.

What goes into the estimated value on the pricing date?

In valuing the securities on the pricing date, we take into account that the securities comprise both a debt component and a performance-based component linked to the underlier. The estimated value of the securities is determined using our own pricing and valuation models, market inputs and assumptions relating to the underlier, instruments based on the underlier, volatility and other factors including current and expected interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest rate at which our conventional fixed rate debt trades in the secondary market.

What determines the economic terms of the securities?

In determining the economic terms of the securities, we use an internal funding rate, which is likely to be lower than our secondary market credit spreads and therefore advantageous to us. If the issuing, selling, structuring and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the economic terms of the securities would be more favorable to you.

What is the relationship between the estimated value on the pricing date and the secondary market price of the securities?

The price at which MS & Co. purchases the securities in the secondary market, absent changes in market conditions, including those related to the underlier, may vary from, and be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and other factors. However, because the costs associated with issuing, selling, structuring and hedging the securities are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the securities in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underlier, and to our secondary market credit spreads, it would do so based on values higher than the estimated value. We expect that those higher values will also be reflected in your brokerage account statements.

MS & Co. may, but is not obligated to, make a market in the securities, and, if it once chooses to make a market, may cease doing so at any time.

 Page 4

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Hypothetical Examples

The following hypothetical examples illustrate how to determine whether the securities will be automatically redeemed with respect to the first redemption determination date, whether a contingent coupon is payable with respect to an observation date and how to calculate the payment at maturity if the securities have not been automatically redeemed prior to maturity. The following examples are for illustrative purposes only. Whether the securities are automatically redeemed prior to maturity will be determined by reference to the closing level of the underlier on the first redemption determination date. Whether you receive a contingent coupon will be determined by reference to the closing level of the underlier on each observation date. The payment at maturity will be determined by reference to the closing level of the underlier on the final observation date. The actual initial level, call threshold level, coupon barrier level and downside threshold level were determined on the strike date. All payments on the securities are subject to our credit risk. The numbers in the hypothetical examples below may have been rounded for ease of analysis. The below examples are based on the following terms:

Stated principal amount:

$1,000 per security

Hypothetical initial level:

$100.00*

Hypothetical call threshold level:

$100.00, which is 100% of the hypothetical initial level

Hypothetical coupon barrier level:

$60.00, which is 60% of the hypothetical initial level

Hypothetical downside threshold level:

$60.00, which is 60% of the hypothetical initial level

Contingent coupon:

47.30% per annum (corresponding to approximately $118.25 per interest period per security). The actual contingent coupon will be an amount determined by the calculation agent based on the number of days in the applicable payment period, calculated on a 30/360 day-count basis. The hypothetical contingent coupon of $118.25 is used in these examples for ease of analysis.

If the contingent coupon is not paid on any coupon payment date (because the closing level of the underlier is less than the coupon barrier level on the related observation date), such unpaid contingent coupon will be paid on a later coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. Any such unpaid contingent coupon will be paid on the first subsequent coupon payment date for which the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date.

*The hypothetical initial level of $100.00 for the underlier has been chosen for illustrative purposes only and does not represent the actual initial level of the underlier. Please see “Historical Information” below for historical data regarding the actual closing levels of the underlier.

 Page 5

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

How to determine whether the securities will be automatically redeemed with respect to the first redemption determination date:

 

Closing Level of the Underlier

Early Redemption Payment

Example #1

$65.00 (less than the call threshold level)

N/A

Example #2

$110.00 (greater than or equal to the call threshold level)

The stated principal amount + the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons

For more information, please see “How to determine whether a contingent coupon is payable with respect to an observation date (if the securities have not been previously automatically redeemed)” below.

In example #1, because the closing level of the underlier is less than the call threshold level on the first redemption determination date, the securities are not automatically redeemed on the early redemption date.

In example #2, because the closing level of the underlier is greater than or equal to the call threshold level on the first redemption determination date, the securities are automatically redeemed on the early redemption date for the early redemption payment equal to the stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons. No further payments are made on the securities once they have been automatically redeemed.

If the closing level of the underlier is less than the call threshold level on the first redemption determination date, the securities will not be automatically redeemed prior to maturity.

How to determine whether a contingent coupon is payable with respect to an observation date (if the securities have not been previously automatically redeemed):

 

Closing Level of the Underlier

Payment per Security

Hypothetical Observation Date #1

$90.00 (greater than or equal to the coupon barrier level)

$118.25

Hypothetical Observation Date #2

$50.00 (less than the coupon barrier level)

$0

Hypothetical Observation Date #3

$95.00 (greater than or equal to the coupon barrier level)

$118.25 + $118.25 = $236.50

Hypothetical Observation Date #4

$45.00 (less than the coupon barrier level)

$0

On hypothetical observation date #1, because the closing level of the underlier is greater than or equal to the coupon barrier level, the contingent coupon is paid on the related coupon payment date.

On hypothetical observation date #2, because the closing level of the underlier is less than the coupon barrier level, no contingent coupon is paid on the related coupon payment date.

On hypothetical observation date #3, because the closing level of the underlier is greater than or equal to the coupon barrier level, investors receive the contingent coupon with respect to hypothetical observation date #3 as well as the previously unpaid contingent coupon with respect to hypothetical observation date #2.

On hypothetical observation date #4, because the closing level of the underlier is less than the coupon barrier level, no contingent coupon is paid on the related coupon payment date.

If the closing level of the underlier is less than the coupon barrier level on each observation date, you will not receive any contingent coupons for the entire term of the securities.

 Page 6

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

How to calculate the payment at maturity (if the securities have not been automatically redeemed):

The hypothetical examples below illustrate how to calculate the payment at maturity if the securities have not been automatically redeemed prior to maturity.

 

Final Level

Payment at Maturity per Security

Example #1

$120.00 (greater than or equal to the downside threshold level)

The stated principal amount + the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons

For more information, please see “How to determine whether a contingent coupon is payable with respect to an observation date (if the securities have not been previously automatically redeemed)” above.

Example #2

$30.00 (less than the downside threshold level)

$1,000 × performance factor = $1,000 × ($30.00 / $100.00) = $300.00

In example #1, the final level is greater than or equal to the downside threshold level. Therefore, investors receive at maturity the stated principal amount. Because the final level is also greater than or equal to the coupon barrier level, investors receive the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons. Investors do not participate in any appreciation of the underlier.

In example #2, the final level is less than the downside threshold level. Therefore, investors receive at maturity a payment that reflects a loss of 1% of principal for each 1% decline in the level of the underlier. Moreover, because the final level is also less than the coupon barrier level, investors do not receive a contingent coupon with respect to the final observation date or any previously unpaid contingent coupons.

If the securities have not been automatically redeemed prior to maturity and the final level is less than the downside threshold level, you will be exposed to the negative performance of the underlier at maturity, and your payment at maturity will be significantly less than the stated principal amount of the securities and could be zero.

 Page 7

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Risk Factors

This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled “Risk Factors” in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.

Risks Relating to an Investment in the Securities

The securities do not guarantee the return of any principal. The terms of the securities differ from those of ordinary debt securities in that they do not guarantee the repayment of any principal. If the securities have not been automatically redeemed prior to maturity and the final level is less than the downside threshold level, the payout at maturity will be an amount in cash that is significantly less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the underlier over the term of the securities. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities.

The securities do not provide for the regular payment of interest. The terms of the securities differ from those of ordinary debt securities in that they do not provide for the regular payment of interest. Instead, the securities will pay a contingent coupon on a coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. However, if the closing level of the underlier is less than the coupon barrier level on any observation date, we will pay no coupon with respect to the applicable interest period. Any such unpaid contingent coupon will be paid on a subsequent coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. You will not receive payment for any such unpaid contingent coupon if the closing level of the underlier is less than the coupon barrier level on each subsequent observation date. It is possible that the closing level of the underlier will remain below the coupon barrier level for extended periods of time or even throughout the entire term of the securities so that you will receive few or no contingent coupons. If you do not earn sufficient contingent coupons over the term of the securities, the overall return on the securities may be less than the amount that would be paid on a conventional debt security of ours of comparable maturity.

Payment of the contingent coupon is based on the closing level of the underlier on only the related observation date at the end of the related interest period. Whether the contingent coupon will be paid on any coupon payment date will be determined at the end of the related interest period based on the closing level of the underlier on the related observation date. As a result, you will not know whether you will receive the contingent coupon on a coupon payment date until near the end of the relevant interest period. Moreover, because the contingent coupon is based solely on the closing level of the underlier on the observation dates, if the closing level of the underlier on any observation date is less than the coupon barrier level, you will not receive a contingent coupon with respect to the related interest period (or any previously unpaid contingent coupons), even if the closing level of the underlier was greater than or equal to the coupon barrier level on other days during that interest period.

Investors will not participate in any appreciation in the value of the underlier. Investors will not participate in any appreciation in the value of the underlier from the strike date to the final observation date, and the return on the securities will be limited to the contingent coupons that are paid with respect to the observation dates on which the closing level of the underlier is greater than or equal to the coupon barrier level. It is possible that the closing level of the underlier will remain below the coupon barrier level for extended periods of time or even throughout the entire term of the securities so that you will receive few or no contingent coupons.

The securities are subject to early redemption risk. The term of your investment in the securities may be shortened due to the automatic early redemption feature of the securities. If the securities are automatically redeemed prior to maturity, you will receive no further payments on the securities, may be forced to invest in a lower interest rate environment and may not be able to reinvest at comparable terms or returns. For the avoidance of doubt, the costs borne by investors in the securities, including the fees and commissions described on the cover page of this document, will not be rebated if the securities are redeemed early. However, under no circumstances will the securities be redeemed prior to the first redemption determination date.

The market price of the securities may be influenced by many unpredictable factors. Several factors, many of which are beyond our control, will influence the value of the securities in the secondary market and the price at which MS & Co. may be willing to purchase or sell the securities in the secondary market. We expect that generally the value of the underlier at any time will affect the value of the securities more than any other single factor. Other factors that may influence the value of the securities include:

othe volatility (frequency and magnitude of changes in value) of the underlier;

ointerest and yield rates in the market;

odividend rates on the underlier;

ogeopolitical conditions and economic, financial, political, regulatory or judicial events that affect the underlier or equity markets generally;

othe availability of comparable instruments;

 Page 8

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

othe occurrence of certain events affecting the underlier that may or may not require an adjustment to the adjustment factor;

othe time remaining until the securities mature; and

oany actual or anticipated changes in our credit ratings or credit spreads.

Some or all of these factors will influence the price that you will receive if you sell your securities prior to maturity. Generally, the longer the time remaining to maturity, the more the market price of the securities will be affected by the other factors described above. For example, you may have to sell your securities at a substantial discount from the stated principal amount if, at the time of sale, the closing level of the underlier is at, below or not sufficiently above the downside threshold level and/or coupon barrier level, or if market interest rates rise.

You can review the historical closing levels of the underlier in the section of this document called “Historical Information.” You cannot predict the future performance of the underlier based on its historical performance. The value of the underlier may be, and has recently been, volatile, and we can give you no assurance that the volatility will lessen. There can be no assurance that the closing level of the underlier will be greater than or equal to the coupon barrier level on any observation date so that you will receive a contingent coupon with respect to the applicable interest period, or that the final level will be greater than or equal to the downside threshold level so that you do not suffer a significant loss on your initial investment in the securities.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities. You are dependent on our ability to pay all amounts due on the securities, and, therefore, you are subject to our credit risk. The securities are not guaranteed by any other entity. If we default on our obligations under the securities, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the securities prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any actual or anticipated decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit risk is likely to adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets. As a finance subsidiary, MSFL has no independent operations beyond the issuance and administration of its securities and will have no independent assets available for distributions to holders of MSFL securities if they make claims in respect of such securities in a bankruptcy, resolution or similar proceeding. Accordingly, any recoveries by such holders will be limited to those available under the related guarantee by Morgan Stanley and that guarantee will rank pari passu with all other unsecured, unsubordinated obligations of Morgan Stanley. Holders will have recourse only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of securities issued by MSFL should accordingly assume that in any such proceedings they would not have any priority over and should be treated pari passu with the claims of other unsecured, unsubordinated creditors of Morgan Stanley, including holders of Morgan Stanley-issued securities.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices. Assuming no change in market conditions or any other relevant factors, the prices, if any, at which dealers, including MS & Co., may be willing to purchase the securities in secondary market transactions will likely be significantly lower than the original issue price, because secondary market prices will exclude the issuing, selling, structuring and hedging-related costs that are included in the original issue price and borne by you and because the secondary market prices will reflect our secondary market credit spreads and the bid-offer spread that any dealer would charge in a secondary market transaction of this type as well as other factors.

The inclusion of the costs of issuing, selling, structuring and hedging the securities in the original issue price and the lower rate we are willing to pay as issuer make the economic terms of the securities less favorable to you than they otherwise would be.

However, because the costs associated with issuing, selling, structuring and hedging the securities are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the securities in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underlier, and to our secondary market credit spreads, it would do so based on values higher than the estimated value, and we expect that those higher values will also be reflected in your brokerage account statements.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price. These pricing and valuation models are proprietary and rely in part on subjective views of certain market inputs and certain assumptions about future events, which may prove to be incorrect. As a result, because there is no market-standard way to value these types of securities, our models may yield a higher estimated value of the securities than those generated by others, including other dealers in the market, if they attempted to value the securities. In addition, the estimated value on the pricing date does not represent a minimum or maximum price at which dealers, including MS & Co., would be willing to purchase your securities in the secondary market (if any exists) at any time. The value of your securities at any time after the date of this document will vary based on many factors that cannot be

 Page 9

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

predicted with accuracy, including our creditworthiness and changes in market conditions. See also “The market price of the securities may be influenced by many unpredictable factors” above.

The securities will not be listed on any securities exchange and secondary trading may be limited. The securities will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. MS & Co. may, but is not obligated to, make a market in the securities and, if it once chooses to make a market, may cease doing so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at prices based on its estimate of the current value of the securities, taking into account its bid/offer spread, our credit spreads, market volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time remaining to maturity and the likelihood that it will be able to resell the securities. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Since other broker-dealers may not participate significantly in the secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease making a market in the securities, it is likely that there would be no secondary market for the securities. Accordingly, you should be willing to hold your securities to maturity.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain. There is no direct legal authority regarding the proper U.S. federal income tax treatment of the securities, and significant aspects of the tax treatment of the securities are uncertain. Moreover, non-U.S. investors should note that persons having withholding responsibility in respect of the securities are, absent an exception, expected to withhold on any coupon paid to a non-U.S. investor, generally at a rate of 30%. We will not pay any additional amounts in respect of such withholding. You should review carefully the section entitled “United States Federal Income Tax Considerations” herein, in combination with the section entitled “United States Federal Income Tax Considerations” in the accompanying product supplement, and consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oWe have no affiliation with any underlying stock issuer.

oWe may engage in business with or involving any underlying stock issuer without regard to your interests.

oThe anti-dilution adjustments the calculation agent is required to make do not cover every corporate event that could affect an underlying stock.

Risks Relating to Conflicts of Interest

In engaging in certain activities described below and as discussed in more detail in the accompanying product supplement, our affiliates may take actions that may adversely affect the value of and your return on the securities, and in so doing they will have no obligation to consider your interests as an investor in the securities.

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities. As calculation agent, MS & Co. will make any determinations necessary to calculate any payment(s) on the securities. Moreover, certain determinations made by MS & Co., in its capacity as calculation agent, may require it to exercise discretion and make subjective judgments, which may adversely affect your return on the securities. In addition, MS & Co. has determined the estimated value of the securities on the pricing date.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

 Page 10

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Historical Information

Hims & Hers Health, Inc. Overview

Bloomberg Ticker Symbol: HIMS

Hims & Hers Health, Inc. operates a digital platform that coordinates health and wellness care for consumers. The underlier is registered under the Securities Exchange Act of 1934, as amended. Information provided to or filed with the Securities and Exchange Commission by the underlying stock issuer pursuant to the Securities Exchange Act of 1934, as amended, can be located by reference to Securities and Exchange Commission file number 001-38986 through the Securities and Exchange Commission’s website at www.sec.gov. In addition, information regarding the underlying stock issuer may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete.

The closing level of the underlier on June 20, 2025 was $64.22. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

Underlier Daily Closing Levels

January 21, 2021* to June 20, 2025

 

*The underlier began trading on January 21, 2021 and therefore has limited historical performance.

This document relates only to the securities referenced hereby and does not relate to the underlier or other securities of the underlying stock issuer. We have derived all disclosures contained in this document regarding the underlier from the publicly available documents described above. In connection with this offering of securities, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying stock issuer. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described above) that would affect the trading price of the underlier (and therefore the closing level of the underlier on the strike date) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning the underlying stock issuer could affect the value received with respect to the securities and therefore the value of the securities.

Neither we nor any of our affiliates makes any representation to you as to the performance of the underlier.

 Page 11

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Additional Terms of the Securities

Please read this information in conjunction with the terms on the cover of this document.

Additional Terms:

If the terms described herein are inconsistent with those described in the accompanying product supplement or prospectus, the terms described herein shall control.

Denominations:

$1,000 per security and integral multiples thereof

Day-count convention:

Interest will be computed on the basis of a 360-day year of twelve 30-day months.

Interest period:

The period from and including the original issue date (in the case of the first interest period) or the previous scheduled coupon payment date, as applicable, to but excluding the following scheduled coupon payment date, with no adjustment for any postponement thereof.

Underlying stock issuer:

Hims & Hers Health, Inc.

Amortization period:

The 6-month period following the issue date

Trustee:

The Bank of New York Mellon

Calculation agent:

Morgan Stanley & Co. LLC (“MS & Co.”)

 Page 12

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Additional Information About the Securities

Additional Information:

Minimum ticketing size:

$10,000 / 10 securities

United States federal income tax considerations:

You should review carefully the section in the accompanying product supplement entitled “United States Federal Income Tax Considerations.” The following discussion, when read in combination with that section, constitutes the full opinion of our counsel, Davis Polk & Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.

Generally, this discussion assumes that you purchased the securities for cash in the original issuance at the stated issue price and does not address other circumstances specific to you, including consequences that may arise due to any other investments relating to an underlier. You should consult your tax adviser regarding the effect any such circumstances may have on the U.S. federal income tax consequences of your ownership of a security.

In the opinion of our counsel, which is based on current market conditions, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid financial contracts with associated coupons, and any coupons as ordinary income, as described in the section entitled “United States Federal Income Tax Considerations—Tax Consequences to U.S. Holders—Securities Treated as Prepaid Financial Contracts with Associated Coupons” in the accompanying product supplement. There is uncertainty regarding this treatment, and the IRS or a court might not agree with it. A different tax treatment could be adverse to you.

We do not plan to request a ruling from the IRS regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In particular, there is a risk that the securities could be characterized as debt instruments for U.S. federal income tax purposes, in which case the tax consequences of an investment in the securities could be different from those described herein and possibly adverse to certain investors. In addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of “prepaid forward contracts” and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect.

Non-U.S. Holders. The U.S. federal income tax treatment of the coupons is unclear. To the extent that we have withholding responsibility in respect of the securities, we would expect generally to treat the coupons paid to Non-U.S. Holders (as defined in the accompanying product supplement) as subject to U.S. withholding tax. Moreover, you should expect that, if the applicable withholding agent determines that withholding tax should apply, it will be at a rate of 30% (or lower treaty rate). In order to claim an exemption from, or a reduction in, the 30% withholding under an applicable treaty, you may need to comply with certification requirements to establish that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult your tax adviser regarding the tax treatment of the coupons.

As discussed under “United States Federal Income Tax Considerations—Tax Consequences to Non-U.S. Holders—Dividend Equivalents under Section 871(m) of the Code” in the accompanying product supplement, Section 871(m) of the Internal Revenue Code and Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. The Treasury regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a “delta” of one. Based on certain representations made by us, our counsel is of the opinion that Section 871(m) should not apply to the securities with regard to Non-U.S. Holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination.

We will not be required to pay any additional amounts with respect to U.S. federal withholding taxes.

You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments, as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

Additional considerations:

Client accounts over which Morgan Stanley, Morgan Stanley Wealth Management or any of their respective subsidiaries have investment discretion are not permitted to purchase the securities, either directly or indirectly.

 Page 13

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Supplemental information regarding plan of distribution; conflicts of interest:

J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. will act as placement agents for the securities. The placement agents will forgo fees for sales to certain fiduciary accounts. The total fees represent the amount that the placement agents receive from sales to accounts other than such fiduciary accounts. The placement agents will receive a fee from the Issuer or one of its affiliates that will not exceed $10 per $1,000 stated principal amount of securities.

MS & Co. is an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley, and it and other affiliates of ours expect to make a profit by selling, structuring and, when applicable, hedging the securities.

MS & Co. will conduct this offering in compliance with the requirements of FINRA Rule 5121 of the Financial Industry Regulatory Authority, Inc., which is commonly referred to as FINRA, regarding a FINRA member firm’s distribution of the securities of an affiliate and related conflicts of interest. MS & Co. or any of our other affiliates may not make sales in this offering to any discretionary account. See “Plan of Distribution (Conflicts of Interest)” and “Use of Proceeds and Hedging” in the accompanying product supplement.

Validity of the securities:

In the opinion of Davis Polk & Wardwell LLP, as special counsel to MSFL and Morgan Stanley, when the securities offered by this pricing supplement have been executed and issued by MSFL, authenticated by the trustee pursuant to the MSFL Senior Debt Indenture (as defined in the accompanying prospectus) and delivered against payment as contemplated herein, such securities will be valid and binding obligations of MSFL and the related guarantee will be a valid and binding obligation of Morgan Stanley, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above and (ii) any provision of the MSFL Senior Debt Indenture that purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law by limiting the amount of Morgan Stanley’s obligation under the related guarantee. This opinion is given as of the date hereof and is limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the MSFL Senior Debt Indenture and its authentication of the securities and the validity, binding nature and enforceability of the MSFL Senior Debt Indenture with respect to the trustee, all as stated in the letter of such counsel dated February 26, 2024, which is Exhibit 5-a to Post-Effective Amendment No. 2 to the Registration Statement on Form S-3 filed by Morgan Stanley on February 26, 2024.

Where you can find more information:

Morgan Stanley and MSFL have filed a registration statement (including a prospectus, as supplemented by the product supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. You should read the prospectus in that registration statement, the product supplement and any other documents relating to this offering that MSFL and Morgan Stanley have filed with the SEC for more complete information about Morgan Stanley and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, MSFL, Morgan Stanley, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the product supplement if you so request by calling toll-free 1-(800)-584-6837.

Terms used but not defined in this document are defined in the product supplement or in the prospectus. Each of the product supplement and the prospectus can be accessed via the hyperlinks set forth on the cover of this document.

 

 Page 14

FAQ

What is the contingent coupon on Morgan Stanley's 424B2 note linked to HIMS?

The note pays a 47.30 % annual coupon when HIMS closes at or above $36.642 on an observation date.

When can the Morgan Stanley auto-call note be redeemed early?

If on Apr 1 2026 HIMS closes at or above $61.07, the securities are automatically redeemed at par plus due coupons.

How much principal protection do investors have on the MS Contingent Income note?

Principal is protected only if the final HIMS price is � $36.642 (60 % of initial). Below that, losses mirror the stock’s decline.

Is the note guaranteed and what credit risk remains?

Payments are unsecured obligations of MSFL and are fully guaranteed by Morgan Stanley; investors still face Morgan Stanley credit risk.

Will the securities be listed on an exchange?

No. The notes will not be listed. Morgan Stanley & Co. may offer limited secondary liquidity but is not obligated to do so.

Why is the estimated value only $964 versus the $1,000 issue price?

The difference reflects issuer funding spread, structuring and hedging costs embedded in the transaction.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

224.20B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
NEW YORK